3-(1-Methyl-1H-indol-3-yl)-7-(4-methylpiperazin-1-yl)quinolin-2-amine

ID: ALA5290790

Max Phase: Preclinical

Molecular Formula: C23H25N5

Molecular Weight: 371.49

Names and Identifiers

Canonical SMILES:  CN1CCN(c2ccc3cc(-c4cn(C)c5ccccc45)c(N)nc3c2)CC1

Standard InChI:  InChI=1S/C23H25N5/c1-26-9-11-28(12-10-26)17-8-7-16-13-19(23(24)25-21(16)14-17)20-15-27(2)22-6-4-3-5-18(20)22/h3-8,13-15H,9-12H2,1-2H3,(H2,24,25)

Standard InChI Key:  ZWOLVKXSUWEJQE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
    3.1765  -17.2600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1754  -18.0796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8834  -18.4885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8817  -16.8512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5903  -17.2564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5937  -18.0816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3060  -18.4890    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0196  -18.0758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0162  -17.2506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2993  -16.8386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7284  -18.4824    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4674  -18.4876    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7227  -16.8398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4669  -17.1676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0119  -16.5586    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8023  -16.0246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6001  -15.8536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8494  -15.0786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3019  -14.4740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5019  -14.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2563  -15.4242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8249  -16.6407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7637  -18.0740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0578  -18.4786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0529  -19.2961    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7601  -19.7074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4722  -19.3012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3366  -19.7053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  8 11  1  0
  2 12  1  0
  9 13  1  0
 13 14  2  0
 14 15  1  0
 15 17  1  0
 16 13  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 15 22  1  0
 12 23  1  0
 12 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 25 28  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5290790

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 371.49

Molecular Weight (Monoisotopic): 371.2110

AlogP: 3.73

#Rotatable Bonds: 2

Polar Surface Area: 50.32

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 8.04

CX LogP: 3.82

CX LogD: 2.94

Aromatic Rings: 4

Heavy Atoms: 28

QED Weighted: 0.58

Np Likeness Score: -0.93

References

1. Hammill JT, Sviripa VM, Kril LM, Ortiz D, Fargo CM, Kim HS, Chen Y, Rector J, Rice AL, Domagalska MA, Begley KL, Liu C, Rangnekar VM, Dujardin JC, Watt DS, Landfear SM, Guy RK..  (2021)  Amino-Substituted 3-Aryl- and 3-Heteroarylquinolines as Potential Antileishmanial Agents.,  64  (16.0): [PMID:34355566] [10.1021/acs.jmedchem.1c00813]

Source

Source(1):

• Scientific Literature